There exists a massive pool of biodiversity in marine ecosystems. This biodiversity is an excellent source for acquiring an inventory of enzymes that can be used for a variety of biotech applications. This diversity has, to date, not been fully exploited. One major reason being the difficulties that arise in culturing many microorganisms in the laboratory, as opposed to natural conditions. However, advents of newer omics techniques, such as metagenomics have greatly enhanced the opportunity for sustainable resource management. It is in this context that metagenomics is rapidly emerging as an alternative approach to conventional microbial screening. Metagenomics allows for exhaustive screening of microbial genomes in their natural environments. In this review, an overview of work that uses genomic strategies to examine the biotechnological potential of the marine reservoir was explored. These genomic strategies include homology-driven screening of enormous amounts of sequence data and activity-based functional screening of genomic and metagenomic libraries. Finally, the review concludes with an overview of some of the potential challenges and future prospects of metagenomics in bioprospecting novel biocatalysts and bioactive compounds from marine sources.
:The evolution of drug resistant strains of important human pathogens has created an urgent necessity to find new targets and novel anti-infective agents such as anti-mycobacterial, anti-malarial and anti-fungal agents. Enoyl acyl carrier protein reductase is one of the most upcoming powerful target. Enoyl ACP reductase enzyme plays most determinant role in Fatty acid synthase II (FAS II) cycle. This review deals with the development made in the design of enoyl acyl carrier protein reductase inhibitors and the role played by 3D structure of the enzyme in drug design process. This review summarized on the recent advances made in the current understanding of enoyl acyl carrier protein reductase (ENR). The review focuses its potential as a promising drug target for future drug development against most anti-infective diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.